The crystal structure of the FAD/NADPH-binding domain of flavocytochrome P450 BM3

FEBS Journal

Volumn 279, Issue 9, 2012, Pages 1694-1706

  Joyce, Michael G ^a,c   Ekanem, Idorenyin S ^b   Roitel, Olivier ^a   Dunford, Adrian J ^b   Neeli, Rajasekhar ^b   Girvan, Hazel M ^b   Baker, George J ^b   Curtis, Robin A ^b   Munro, Andrew W ^b   Leys, David ^b  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

crystal structure; cytochrome P450; dimerization; FAD domain; P450 BM3

Indexed keywords

CYTOCHROME P450 BM3; DITHIOTHREITOL; FLAVODOXIN; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; PYROPHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

AMINO ACID SEQUENCE; ARTICLE; BACILLUS MEGATERIUM; BINDING SITE; CRYSTAL STRUCTURE; CRYSTALLIZATION; ENZYME BINDING; ENZYME KINETICS; ENZYME STRUCTURE; FAD DOMAIN; LIGHT SCATTERING; MOLECULAR MODEL; MUTAGENESIS; PRIORITY JOURNAL; REDUCTION;

AMINO ACID SEQUENCE; BACTERIAL PROTEINS; BINDING SITES; CRYSTALLOGRAPHY, X-RAY; CYTOCHROME P-450 ENZYME SYSTEM; FLAVIN-ADENINE DINUCLEOTIDE; LASERS; MODELS, MOLECULAR; MUTATION; NADP; NADPH-FERRIHEMOPROTEIN REDUCTASE; SCATTERING, RADIATION;

BACILLUS MEGATERIUM;

EID: 84860214353     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2012.08544.x     Document Type: Article

References (61)

1. Nelson DR, (2006) Cytochrome P450 nomenclature. Methods Mol Biol 320, 1-10.
2. Munro AW, Leys DG, McLean KJ, Marshall KR, Ost TW, Daff S, Miles CS, Chapman SK, Lysek DA, Moser CC, et al. (2002) P450 BM3: the very model of a modern flavocytochrome. Trends Biochem Sci 27, 250-257. (Pubitemid 34655446)
3. Murataliev MB, Feyereisen R, &, Walker FA, (2004) Electron transfer by diflavin reductases. Biochim Biophys Acta 1698, 1-26. (Pubitemid 38446896)
4. Munro AW, Girvan HM, &, McLean KJ, (2007) Cytochrome P450-redox partner fusion enzymes. Biochim Biophys Acta 1770, 345-359. (Pubitemid 46136745)
5. Lee DS, Yamada A, Sugimoto H, Matsunaga I, Ogura H, Ichihara K, Adachi S, Park SY, &, Shiro Y, (2003) Substrate recognition and molecular mechanism of fatty acid hydroxylation by cytochrome P450 from Bacillus subtilis. Crystallographic, spectroscopic, and mutational studies. J Biol Chem 278, 9761-9767. (Pubitemid 36800475)
6. Daiber A, Shoun H, &, Ullrich V, (2005) Nitric oxide reductase (P450nor) from Fusarium oxysporum. J Inorg Biochem 99, 185-193. (Pubitemid 39642978)
7. Lawson RJ, von Wachenfeldt C, Haq I, Perkins J, &, Munro AW, (2004) Expression and characterization of the two flavodoxin proteins of Bacillus subtilis, YkuN and YkuP: biophysical properties and interactions with cytochrome P450 BioI. Biochemistry, 43, 12390-12409. (Pubitemid 39314702)
8. Narhi LO, &, Fulco AJ, (1987) Identification and characterization of two functional domains in cytochrome P-450BM-3, a catalytically self-sufficient monooxygenase induced by barbiturates in Bacillus megaterium. J Biol Chem 262, 6683-6690.
9. Miles JS, Munro AW, Rospendowski BN, Smith WE, McKnight JE, &, Thomson AJ, (1992) Domains of the catalytically self-sufficient cytochrome P-450 BM-3. Genetic construction, overexpression, purification and spectroscopic characterization. Biochem J 288, 503-509.
10. Li HY, Darwish K, &, Poulos TL, (1991) Characterization of recombinant Bacillus megaterium cytochrome P-450 BM-3 and its two functional domains. J Biol Chem 266, 11909-11914. (Pubitemid 21907036)
11. Noble MA, Miles CS, Chapman SK, Lysek DA, MacKay AC, Reid GA, Hanzlik RP, &, Munro AW, (1999) Roles of key active-site residues in flavocytochrome P450 BM3. Biochem J 339, 371-379. (Pubitemid 29209968)
12. Neeli R, Girvan HM, Lawrence A, Warren MJ, Leys D, Scrutton NS, &, Munro AW, (2005) The dimeric form of flavocytochrome P450 BM3 is catalytically functional as a fatty acid hydroxylase. FEBS Lett 579, 5582-5588. (Pubitemid 41455634)
13. Fulco AJ, (1991) P450BM-3 and other inducible bacterial P450 cytochromes: biochemistry and regulation. Annu Rev Pharmacol Toxicol 31, 177-203. (Pubitemid 21903846)
14. Black SD, &, Martin ST, (1994) Evidence for conformational dynamics and molecular aggregation in cytochrome P450 102 (BM-3). Biochemistry, 33, 12056-12062. (Pubitemid 24328020)
15. Kitazume T, Haines DC, Estabrook RW, Chen B, &, Peterson JA, (2007) Obligatory intermolecular electron transfer from FAD to FMN in dimeric P450 BM-3. Biochemistry 46, 11892-11901. (Pubitemid 47623757)
16. Girvan HM, Dunford AJ, Neeli R, Ekanem IS, Waltham TN, Joyce MG, Leys D, Curtis RA, Williams P, Fisher K, et al. (2011) Flavocytochrome P450 BM3 mutant W1046A is a NADH-dependent fatty acid hydroxylase: implications for the mechanism of electron transfer in the P450 BM3 dimer. Arch Biochem Biophys 507, 75-85.
17. Oster T, Boddupalli SS, &, Peterson JA, (1991) Expression, purification, and properties of the flavoprotein domain of cytochrome P-450BM-3. Evidence for the importance of the amino-terminal region for FMN binding. J Biol Chem 266, 22718-22725. (Pubitemid 21908707)
18. Porter TD, (1991) An unusual yet strongly conserved flavoprotein reductase in bacteria and mammals. Trends Biochem Sci 16, 154-158. (Pubitemid 121004424)
19. Ravichandran KG, Boddupalli SS, Hasemann CA, Peterson JA, &, Deisenhofer J, (1993) Crystal structure of hemoprotein domain of P450BM-3, a prototype for microsomal P450s. Science 261, 731-736. (Pubitemid 23278388)
20. Li H, &, Poulos TL, (1997) The structure of the cytochrome P450BM-3 haem domain complexed with the fatty acid substrate, palmitoleic acid. Nat Struct Biol 4, 140-146. (Pubitemid 27066389)
21. Girvan HM, Marshall KR, Lawson RJ, Leys D, Joyce MG, Clarkson J, Smith WE, Cheesman MR, &, Munro AW, (2004) Flavocytochrome P450 BM3 mutant A264E undergoes substrate-dependent formation of a novel heme iron ligand set. J Biol Chem 279, 23274-23286. (Pubitemid 38685636)
22. Girvan HM, Seward HE, Toogood HS, Cheesman MR, Leys D, &, Munro AW, (2007) Structural and spectroscopic characterization of P450 BM3 mutants with unprecedented P450 heme iron ligand sets. New heme ligation states influence conformational equilibria in P450 BM3. J Biol Chem 282, 564-572. (Pubitemid 47076604)
23. Sevrioukova IF, Li H, Zhang H, Peterson JA, &, Poulos TL, (1999) Structure of a cytochrome P450-redox partner electron-transfer complex. Proc Natl Acad Sci USA 96, 1863-1868. (Pubitemid 29117833)
24. Hanley SC, Ost TW, &, Daff S, (2004) The unusual redox properties of flavocytochrome P450 BM3 flavodoxin domain. Biochem Biophys Res Commun 325, 1418-1423. (Pubitemid 39535919)
25. Murataliev MB, Klein M, Fulco AJ, &, Feyereisen R, (1997) Functional interactions in cytochrome P450BM3: flavin semiquinone intermediates, role of NADP(H), and mechanism of electron transfer by the flavoprotein domain. Biochemistry 36, 8401-8412. (Pubitemid 27297552)
26. Klein ML, &, Fulco AJ, (1993) Critical residues involved in FMN binding and catalytic activity in cytochrome P450BM-3. J Biol Chem 268, 7553-7561. (Pubitemid 23105657)
27. Roitel O, Scrutton NS, &, Munro AW, (2003) Electron transfer in flavocytochrome P450 BM3: kinetics of flavin reduction and oxidation, the role of cysteine 999, and relationships with mammalian cytochrome P450 reductase. Biochemistry 42, 10809-10821. (Pubitemid 37102121)
28. Neeli R, Roitel O, Scrutton NS, &, Munro AW, (2005) Switching pyridine nucleotide specificity in P450 BM3: mechanistic analysis of the W1046H and W1046A enzymes. J Biol Chem 280, 17634-17644. (Pubitemid 41388998)
29. Govindaraj S, &, Poulos TL, (1997) The domain architecture of cytochrome P450 BM-3. J Biol Chem 272, 7915-7921. (Pubitemid 27137352)
30. Daff SN, Chapman SK, Turner KL, Holt RA, Govindaraj S, Poulos TL, &, Munro AW, (1997) Redox control of the catalytic cycle of flavocytochrome P450 BM3. Biochemistry 36, 13816-13823. (Pubitemid 27494887)
31. Wang M, Roberts DL, Paschke R, Shea TM, Masters BS, &, Kim JJ, (1997) Three dimensional structure of NADPH-cytochrome P450 reductase: prototype for FMN- and FAD-containing enzymes. Proc Natl Acad Sci USA 94, 8411-8416. (Pubitemid 27335052)
32. Munro AW, Daff S, Coggins JR, Lindsay JG, &, Chapman SK, (1996) Probing electron transfer in flavocytochrome P450 BM3 and its component domains. Eur J Biochem 239, 403-409. (Pubitemid 26246547)
33. Ingelman M, Bianchi V, &, Eklund H, (1997) The three dimension structure of flavodoxin reductase from Escherichia coli at 1.7 Å resolution. J Mol Biol 268, 147-157. (Pubitemid 27192685)
34. + oxidoreductase and flavodoxin: key components of electron transfer in Escherichia coli. Eur J Biochem 257, 577-585. (Pubitemid 28512125)
35. Bruns CM, &, Karplus PA, (1995) Refined crystal structure of spinach ferredoxin reductase at 1.7 Å resolution: oxidized, reduced and 2'-phospho-5'-AMP bound states. J Mol Biol 247, 125-145.
36. Warman AJ, Roitel O, Neeli R, Girvan HM, Seward HE, Murray SA, McLean KJ, Joyce MG, Toogood H, Holt RA, et al. (2005) Flavocytochrome P450 BM3: an update on structure and mechanism of a biotechnologically important enzyme. Biochem Soc Trans 33, 747-753. (Pubitemid 41160856)
37. Ellis J, Gutierrez A, Barsukov IL, Huang WC, Grossman JG, &, Roberts GC, (2009) Domain motion in cytochrome P450 reductase: conformational equilibria revealed by NMR and small-angle X-ray scattering. J Biol Chem 284, 36628-36637.
38. Shen AL, Sem DS, &, Kasper CB, (1999) Mechanistic studies on the reductive half-reaction of NADPH-cytochrome P450 oxidoreductase. J Biol Chem 274, 5391-5398. (Pubitemid 29109183)
39. Garcin EC, Bruns CM, Lloyd SJ, Hosfield DJ, Tiso M, Gachhui R, Stuehr DJ, Tainer JA, &, Getzoff ED, (2004) Structural basis for isoform-specific regulation of electron transfer in nitric-oxide synthase. J Biol Chem 279, 37918-37927. (Pubitemid 39195507)
40. Munro AW, Lindsay JG, Coggins JR, Kelly SM, &, Price NC, (1994) Structural and ezymological analysis of the interactions of isolated domains of cytochrome P-450 BM3. FEBS Lett 343, 70-74. (Pubitemid 24123949)
41. Page CC, Moser CC, Chen X, &, Dutton PL, (1999) Natural engineering principles of electron tunnelling in biological oxidation-reduction. Nature 402, 47-52.
42. Dym O, &, Eisenberg D, (2001) Sequence-structure analysis of FAD-containing proteins. Protein Sci 10, 1712-1728. (Pubitemid 32848768)
43. Dunford AJ, Girvan HM, Scrutton NS, &, Munro AW, (2009) Probing the molecular determinants of coenzyme selectivity in the P450 BM3 FAD/NADPH domain. Biochim Biophys Acta 1794, 1181-1189.
44. Döhr O, Paine MJI, Friedberg T, Roberts GCK, &, Wolf CR, (2001) Engineering of a functional human NADH-dependent cytochrome P450 system. Proc Natl Acad Sci USA 91, 81-86. (Pubitemid 32095867)
45. Gutierrez A, Grunau A, Paine M, Munro AW, Wolf CR, Roberts GCK, &, Scrutton NS, (2003) Electron transfer in human cytochrome P450 reductase. Biochem Soc Trans 31, 497-501. (Pubitemid 36750719)
46. + reductase revealed by protein engineering and crystallographic studies. Nat Struct Biol 6, 847-853. (Pubitemid 29415177)
47. Hubbard PA, Shen AL, Paschke R, Kasper CB, &, Kim JJ, (2001) NADPH-cytochrome P450 reductase oxidordeductase. Structural basis for hydride and electron transfer. J Biol Chem 276, 29136-29170.
48. Karlsson A, Beharry ZM, Eby MD, Coulter ED, Neidle EL, Kurtz DM Jr, &, Ramaswamy S, (2002) X-Ray crystal structure of benzoate 1,2-dioxygenase reductase from Acinetobacter sp. strain ADP1. J Mol Biol 318, 261-272. (Pubitemid 34742015)
49. Siddhanta U, Presta A, Fan B, Wolan D, Rousseau DL, &, Stuehr DJ, (1998) Domain swapping in inducible nitric-oxide synthase. Electron transfer occurs between flavin and heme groups on adjacent subunits in the dimer. J Biol Chem 273, 18950-18958. (Pubitemid 28366284)
50. Peters MW, Meinhold P, Glieder A, &, Arnold FH, (2005) Regio- and enantioselective alkane hydroxylation with engineered cytochromes P450 BM-3. J Am Chem Soc 125, 13442-13450. (Pubitemid 37352128)
51. Ost TW, Miles CS, Murdoch J, Cheung Y, Reid GA, Chapman SK, &, Munro AW, (2000) Rational re-design of the substrate binding site of flavocytochrome P450 BM3. FEBS Lett 486, 173-177.
52. Whitehouse CJ, Bell SG, &, Wong LL, (2008) Desaturation of alkylbenzenes by cytochrome P450 BM3 (CYP102A1). Chemistry 14, 10905-10908.
53. Shapiro MG, Westmeyer GG, Romero PA, Szablowski JO, Küster B, Shah A, Otey CR, Langer R, Arnold FH, &, Jasanoff A, (2010) Directed evolution of a magnetic resonance imaging contrast agent for noninvasive imaging of dopamine. Nat Biotechnol 28, 264-270.
54. Whitehouse CJ, Bell SG, &, Wong LL, (2012) P450 BM3 (CYP102A1): connecting the dots. Chem Soc Rev 41, 1218-1260.
55. Otwinowski Z, &, Minor W, (1997) Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol 276, 307-326. (Pubitemid 27085611)
56. Navazza J, (2001) Implementation of molecular replacement in AMoRe. Acta Crystallogr D 57, 1367-1372.
57. Murshudov GN, Vagin AA, &, Dodson EJ, (1997) Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D 53, 240-255. (Pubitemid 27235885)
58. Roussel A, &, Cambillau C, (1992) TURBO-FRODO. Biographics, Architecture et Fonction de Macromolécules Biologiques (AFMB), Marseilles, France.
59. Perrakis A, Harkiolaki M, Wilson KS, &, Lamzin VS, (2001) ARP/wARP and molecular replacement. Acta Crystallogr D 57, 1445-1450. (Pubitemid 36117195)
60. Laskowski RA, MacArthur MW, Moss DS, &, Thornton JM, (1993) PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Crystallogr 26, 283-291.
61. Hooft RW, Sander C, &, Vriend G, (1996) Positioning hydrogen atoms by optimizing hydrogen-bond networks in protein structures. Proteins 26, 363-376. (Pubitemid 27024754)